4.7 Editorial Material

Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update

期刊

JOURNAL OF CLINICAL ONCOLOGY
卷 39, 期 28, 页码 3182-+

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.21.01831

关键词

-

类别

资金

  1. Merck
  2. Oncolys BioPharma
  3. Bristol Myers Squibb

向作者/读者索取更多资源

The ASCO Rapid Recommendations Updates aim to disseminate updated recommendations in a timely manner to provide better information on cancer care.
ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据